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Infrared multiple photon dissociation (IRMPD) spectroscopy is used to identify the structure
of the b2
 ion generated from protonated tri-alanine by collision induced dissociation (CID).
The IRMPD spectrum of b2
 differs markedly from that of protonated cyclo-alanine-alanine,
demonstrating that the product is not a diketopiperazine. Instead, comparison of the IRMPD
spectrum of b2
 to spectra predicted by density functional theory provides compelling evidence
for an oxazolone structure protonated at the oxazolone N-atom. (J Am Soc Mass Spectrom
2009, 20, 334–339) © 2009 Published by Elsevier Inc. on behalf of American Society for Mass
SpectrometryBecause tandem mass spectrometry (MS/MS)and collision induced dissociation (CID) are es-sential tools for protein identification in proteom-
ics, a clear understanding of peptide ion dissociation/
fragmentation mechanisms is essential to optimize
bioinformatics approaches for rapid and accurate iden-
tification. Theoretical and experimental evidence exist
for a mix of protonation sites on gas-phase peptides,
including the amino-terminus, amide carbonyl oxygen
atoms [1, 2], and the side chains of histidine, lysine, or
arginine. Fragmentation during low-energy CID pri-
marily involves rearrangement reactions [3–12] in
which the added proton migrates from the most basic
site to the amide bond that is cleaved. This general idea
makes up the “mobile-proton” model of peptide disso-
ciation [13–25], which has been augmented in the more
recent “pathways in competition” model [26] including
more comprehensive pre- and postdissociation pro-
cesses as well as the energies of reactive configurations,
intermediates, and transition states.
Knowledge of structures, particularly for product
ions, is necessary to fully resolve the mechanisms
behind peptide dissociation. Early experimental studies
suggested that the C-terminus-containing y fragments
are simple truncated peptides [6, 27, 28]. While the
complementary, N-terminus-containing b species were
originally thought to be acylium ions [29], it is now
generally accepted they instead have a five-membered
oxazolone ring structure [4, 5].
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doi:10.1016/j.jasms.2008.10.012An alternative b ion structure, particularly for b2
,
would be a six-membered diketopiperazine ring formed
by nucleophilic attack on an amide carbonyl C atom by
the N-terminal amino group. Neutralization-reionization
experiments by Wesdemiotis and coworkers [28] pro-
vided evidence that the neutral eliminated from proton-
ated tri-alanine to furnish y1
 can adopt a diketopipera-
zine structure. However, similar experiments showed
that the b2
 species, which is the complementary frag-
ment to y1
 generated by cleavage of the same amide
bond, is not a diketopiperazine. Further evidence
against a diketopiperazine structure for b2
 ions was
obtained by comparing CID spectra generated from the
b2
 fragment of GLG with those generated from cy-
clo-GL [6].
Formation of b2
 from tri-glycine either as an ox-
azolone or a diketopiperazine was studied in great
detail by Paizs and Suhai using density functional
theory (DFT) calculations and RRKM modeling [9, 30].
Formation of a diketopiperazine ring from protonated
tri-glycine was found to involve a trans-cis isomeriza-
tion of the N-terminal amide bond that is energetically
feasible under the conditions typical of CID [9]. The
other cis amide bond within the diketopiperazine is a
product of the nucleophilic attack cleaving the amide
bond. The cis isomer was found to lie very close to the
all-trans isomer, which is the global minimum for
the protonated peptide. The energetics for the dike-
topiperazine and oxazolone pathways were compared
directly [30], and the barrier, relative to the ground
state, was found to be significantly higher (ca. 10
kcal/mol) for the diketopiperazine pathway, although
the relative energies of the two products are compara-
ble. In addition, it was proposed that the diketopipera-
zine pathway may be kinetically controlled due to the
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the six-membered ring product unfavorable.
Within the context of determining peptide frag-
ment ion structures, infrared multiple photon disso-
ciation (IRMPD) spectroscopy has been used to char-
acterize fragment ions from protonated peptides. For
example, it was shown that b4
 from protonated leucine-
enkephalin has an oxazolone structure [11, 12]. In
addition, McLafferty rearrangement was used to gener-
ate the free-acid forms of the nicotinyl-glycine-tert-butyl
ester and betaine-glycine-tert-butyl ester through trans-
fer of an H atom and elimination of butane [31].
Comparison of the IRMPD and theoretical spectra for
different isotopically-labeled isomers showed that the
H atom is situated at the C-terminal acid group, and
migration to amide positions is negligible on the time
scale of the experiment.
Here we use IRMPD spectroscopy to unambiguously
assign the structure of the b2
 fragment ion from pro-
tonated tri-alanine, and to compare the IR spectrum of
b2
 to that of cyclo-alanine-alanine, and thus provide the
first direct spectroscopic comparison. The experimental
IR spectra are complemented by DFT calculations,
which give relative energies and predicted vibrational
frequencies of potential oxazolone and diketopipera-
zine structures. The IR spectra unambiguously identify
the b2
 ion as an oxazolone structure and provide
valuable vibrational signatures for protonated oxazolo-
nes and diketopiperazines that may be useful in future
studies of peptide fragments by IRMPD spectroscopy.
Experimental
IRMPD Spectroscopy
Infrared spectra were obtained by IRMPD spectroscopy
using the FTICR mass spectrometer coupled to the
beamline of the free-electron-laser user facility (FELIX)
in The Netherlands as described previously [32, 33].
Briefly, ions are produced by electrospray ionization
(ESI) and accumulated in a hexapole ion trap. Ions are
then injected into a homebuilt FTICR mass spectrome-
ter [34], where the ion of interest is isolated and then
irradiated with FELIX for 2 s at a 5 Hz repetition rate. In
these experiments, the wavelength of FELIX is tuned
between 5.2 and 17 m and the macropulse energy is 35
mJ. After irradiation, parent and fragment ion intensities
are recorded. Data acquisition and instrument control is
accomplished using a modified version of the data system
and software of Heeren and coworkers [35].
Tri-alanine and cyclo-dialanine (alanine anhydride,
3,6-dimethyl-2,5-piperazinedione) were used as 1 mM
solutions in 80/20 methanol/water with 1% acetic
acid added to aid protonation. ESI of the cyclo-
dialanine solution yields an abundant protonated
cyclo-dialalanine at m/z 143. Similarly, a strong m/z
232 peak is generated using the tri-alanine solution. Byadjusting the rf amplitude and the axial trapping volt-
age of the accumulation hexapole, conditions can be
made such that the b2
 ion (m/z 143) is formed by CID.
Upon resonant infrared irradiation with FELIX, pro-
tonated cyclo-dialanine fragments into m/z 115, 98, and
44, presumably corresponding to loss of CO, to loss of
CO and NH3, and to H2N
  CH(CH3), respectively.
The fragment intensities are summed and divided by
the total ion intensity at each wavelength to generate an
IRMPD spectrum. Under similar irradiation conditions,
the b2
 fragment of protonated AAA dissociates into m/z
115, i.e., by the loss of CO, presumably forming the a2

ion.
Density Functional Theory Calculations
The Gaussian set of programs [36] is used for all DFT
calculations. A range of protonated oxazolone and dik-
etopiperazine structures are initially (fully) optimized
at the B3LYP/6-31G(d) level of theory, and then reop-
timized at the B3LYP/6-31G(d,p) and B3LYP/6-
311G(d,p) levels of theory. Because of the small size of
the model systems, an intensive search of the peptide
potential energy surface using molecular dynamics
simulations was not deemed necessary. Relative ener-
gies for all species are calculated by correcting B3LYP/
Figure 1. Comparison of the experimental IRMPD spectra re-
corded for the b2
 fragment of protonated tri-alanine and for
protonated cyclo-dialanine. The large differences in the IR spectra
suggest isomeric structures.
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energy (ZPE) obtained from the unscaled frequencies
determined at the same level of theory. Predicted IR
spectra for a range of structural isomers of the ox-
azolone and diketopiperazine b2
 species are generated
at the B3LYP/6-311g(d,p) level of theory and scaled
by a factor of 0.98 for comparison to the experimental
IRMPD spectra.
Figure 2. Experimental IRMPD spectrum of pr
Table 1. Electronic energies, zero-point corrections, and
relative energies for possible oxazolone and diketopiperazine
structures for b2
. Electronic energies and zero-point corrections
are in Hartrees. Relative energies are in kcal/mol. All values
were produced at the B3LYP/6-311g(d,p) level of theory
Structure Energy ZPE E  ZPE Rel. E
ox_1 -495.128188 0.176564 -494.951624 2.36
ox_2 -495.118188 0.176165 -494.942023 8.39
ox_3 -495.114795 0.177805 -494.93699 11.55
ox_4 -495.121278 0.17776 -494.943518 7.45
ox_5 -494.963817 0.175602 -494.788215 104.90
ox_6 -494.940618 0.173196 -494.767422 117.95
diketo_1 -495.13325 0.177859 -494.955391 0
diketo_2 -495.129922 0.177732 -494.95219 2.01
diketo_3 -495.112373 0.177808 -494.934565 13.07for three low-energy structures. The match with theResults and Discussion
The experimental IRMPD spectra for protonated cyclo-AA
and the b2
 fragment of protonated AAA (Figure 1) are very
different, indicating that the two species, despite being
isobaric, possess different structures. From this result
alone, one can qualitatively conclude that the b2
 fragment
of AAAH does not have a diketopiperazine structure.
Relative energies for potential oxazolone and di-
ketopiperazine structures are provided in Table 1.
The lowest energy isomer is an O-protonated diketop-
iperazine, diketo_1. A second O-protonated isomer,
diketo_2, differing only in the NCOH dihedral angle,
and a N-protonated isomer, diketo_3, are 2.01 and 13.07
kcal/mol higher in energy, respectively. The lowest en-
ergy oxazolone isomer, ox_1, which is protonated at the
ring N atom, lies 2.36 kcal/mol higher than diketo_1. A
second oxazolone ring protonated structure (ox_2), and
two amino N-protonated isomers, ox_3 and ox_4, lie
8.39, 11.55, and 7.45 kcal/mol higher in energy, respec-
tively. Additional ring O-protonated oxazolone struc-
tures (not shown) are more than 100 kcal/mol higher in
energy than diketo_1 and are thus ruled out as proba-
ble isomers for b2
.
ted cyclo-AA compared with calculated spectraotona
0 kcal/mol conformer is excellent.
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of protonated cyclo-AA compared with calculated spec-
tra for the three lowest energy diketopiperazine struc-
tures. As noted above, protonation of the dike-
topiperazine at one of the carbonyl oxygen atoms is
preferred over protonation at the amide nitrogen
atom by more than 10 kcal/mol. The spectra predicted
for the two O-protonated structures are very similar.
Apart from small differences in relative band intensi-
ties, the main difference is the small shift in the band
between 1650 and 1700 cm1, which has mainly amide
CN stretching character. In addition, the predicted
spectra show differences in the weak bands between
600 and 800 cm1. These modes are mainly attributed
to various NH and CH-bending modes. Despite the
spectral differences being so small, the experimental
spectrum unambiguously identifies the lowest energy
diketo_1 structure as the actual one. The overall agree-
ment of experiment and theory is excellent, both in
band positions and in relative intensities.
Figure 3. Experimental IRMPD spectrum of t
calculated spectra for four low-energy oxazolon
lowest energy cyclo-AA isomer. The excellent
structure leaves little doubt that this b fragmen2
N atom.As qualitatively concluded from Figure 1, the b2

fragment of protonated AAA does not have a proton-
ated diketopiperazine structure. Hence we compare our
IRMPD spectrum with computed spectra for different
oxazolone conformers (Figure 3). The top two structures
are protonated at the oxazolone N atom (ox_1 and
ox_2), while the bottom two structures are protonated
at the amino group (ox_3 and ox_4). From the better
match of the oxazolone C  O stretch, experimentally
observed at 1950 cm1, as well as from the substantially
better match in the 1400–1800 cm1 range, clearly the
b2
 fragment of AAAH has an oxazolone structure
protonated at the oxazolone N-atom. The band ob-
served at 1620 cm1 is attributed to an NH2 scissoring
mode of the unprotonated N-terminus. In the terminal
N protonated species, two separated bands are pre-
dicted, which are due to the oxazolone C  N stretch
mode and wagging of the NH3
 protonated N-terminus. It
is interesting to note that the b4
 fragment ion from
Leu-enkephalin was spectroscopically determined to be
fragment of protonated AAA compared with
ctures. Energies are given relative to that of the
between experiment and theory for the ox_1
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ring [11].
The two oxazolone protonated conformers ox_1 and
ox_2, represented in the top two panels of Figure 3,
differ mainly in the torsional angle around the C–C
bond connecting the oxazolone ring and the backbone.
The lowest energy ox_1 structure gains its stability from
a hydrogen bond between the proton on the oxazolone
nitrogen atom and the N-terminus. (Note again that
energies are given relative to the lowest energy diketo-
piperazine structure, which represents the global min-
imum for the m/z 143 isomers.) The calculated spectra
for the two oxazolone protonated conformers are very
similar, and it is difficult to exclude one of them on
purely spectroscopic grounds. Perhaps the lack of an
experimental band at the red edge of the scan range
reveals that the structure indeed contains an NH–NH2
hydrogen bond between the oxazolone ring and the
N-terminus. The band calculated around 600 cm1 in
the ox_2 conformer is due to the free NH bending of the
protonated oxazolone. In addition, the calculated en-
ergy difference of6 kcal/mol supports the assignment
of the b2
 fragment ion as the ox_1 structure.
Conclusions
IRMPD spectroscopy and DFT calculations unambigu-
ously indicate that the b2
 fragment from AAAH
has an oxazolone structure protonated at the oxazolone
N-atom. The experimental spectrum of protonated
cyclo-alanine-alanine is assigned to an O-protonated
diketopiperazine structure; even small structural details
such as the NCOH dihedral angle are correctly identi-
fied in the experimental spectrum.
Formation of the oxazolone structure is consistent
with earlier neutralization-reionization mass spectrom-
etry and CID studies of tri-alanine and similar small
peptides [6, 28], and with the DFT studies of Paizs and
Suhai [9, 30]. We note that the experiments reported in
this study involve only a small peptide. Possibly larger
peptides, especially tryptic peptides, will generate b2
ions that have alternate structures [37]. Beyond identi-
fying the structure of b2
 from tri-alanine, these results
provide useful benchmarks and characteristic vibra-
tional fingerprints of oxazolone and diketopiperazine
conformations for future studies.
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